Oxysterols and symptomatic versus asymptomatic human atherosclerotic plaque

Biochemical and Biophysical Research Communications

Volumn 446, Issue 3, 2014, Pages 709-713

  Khatib, Soliman ^a   Vaya, Jacob ^a,b  

^a MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^b TEL HAI COLLEGE   (Israel)

Author keywords

Asymptomatic; Atherosclerosis; Oxysterols; Plaque; Symptomatic

Indexed keywords

7 BETA HYDROXYLATED CHOLESTEROL; 7 OXOCHOLESTEROL; BETA1 INTEGRIN; CATHEPSIN; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL; EARLY GROWTH RESPONSE FACTOR 1; GELATINASE A; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; OXYSTEROL; PROTEIN P53; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

APOPTOSIS; ARTERY MUSCLE; ARTIFICIAL EMBOLISM; ASYMPTOMATIC DISEASE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BILE ACID SYNTHESIS; CARDIOVASCULAR MAGNETIC RESONANCE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CELL DEATH; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CRYSTALLIZATION; CYTOTOXICITY; DISEASE COURSE; DNA DAMAGE; EXTRACELLULAR MATRIX; FOAM CELL; HISTOLOGY; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPID PEROXIDATION; MACROPHAGE; MEDICAL SOCIETY; MONOCYTE; OXIDATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; T LYMPHOCYTE; TRANSIENT ISCHEMIC ATTACK; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ASYMPTOMATIC; ATHEROSCLEROSIS; OXYSTEROLS; PLAQUE; SYMPTOMATIC;

BIOLOGICAL MARKERS; CHOLESTEROL; CORONARY ARTERY DISEASE; HUMANS; HYDROXYCHOLESTEROLS; KETOCHOLESTEROLS; PLAQUE, ATHEROSCLEROTIC;

EID: 84898816567     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.12.116     Document Type: Review

References (57)

1. M. Aviram Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases Free Radic. Res. 33 Suppl. 2000 S85 97
2. J.A. Berliner, M. Navab, A.M. Fogelman, J.S. Frank, L.L. Demer, P.A. Edwards, A.D. Watson, and A.J. Lusis Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics Circulation 91 1995 2488 2496
3. C.K. Glass, and J.L. Witztum Atherosclerosis. The road ahead Cell 104 2001 503 516
4. A.J. Lusis Atherosclerosis Nature 407 2000 233 241
5. R. Stocker, and J.F. Keaney Jr. Role of oxidative modifications in atherosclerosis Physiol. Rev. 84 2004 1381 1478
6. B. Fuhrman, M. Shiner, N. Volkova, and M. Aviram Cell-induced copper ion-mediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiation Free Radic. Biol. Med. 37 2004 259 271
7. A.T. Diplock, J.L. Charleux, G. Crozier-Willi, F.J. Kok, C. Rice-Evans, M. Roberfroid, W. Stahl, and J. Vina-Ribes Functional food science and defence against reactive oxidative species Br. J. Nutr. 80 Suppl 1 1998 S77 112
8. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine fourth ed. 2007 Oxford university press Oxford, UK
9. N. Khan-Merchant, M. Penumetcha, O. Meilhac, and S. Parthasarathy Oxidized fatty acids promote atherosclerosis only in the presence of dietary cholesterol in low-density lipoprotein receptor knockout mice J. Nutr. 132 2002 3256 3262
10. J.J. Badimon, V. Fuster, J.H. Chesebro, and L. Badimon Coronary atherosclerosis. A multifactorial disease Circulation 87 1993 II3 16
11. J.L. Witztum, and D. Steinberg Role of oxidized low density lipoprotein in atherogenesis J. Clin. Invest. 88 1991 1785 1792
12. J. Vaya, M. Aviram, S. Mahmood, T. Hayek, E. Grenadir, A. Hoffman, and S. Milo Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins Free Radic. Res. 34 2001 485 497
13. K.L. Carpenter, S.E. Taylor, C. van der Veen, B.K. Williamson, J.A. Ballantine, and M.J. Mitchinson Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development Biochim. Biophys. Acta 1256 1995 141 150
14. J.B. Marsillach, F. M. M. R. Beltran, J. Joven, J. Camp, Immunohistochemical analysis of Paraxoxnase-1,2 and 3 in human atheroma plaques, III International Conference on Paraoxnases (2008).
15. B. Mackness, R. Hunt, P.N. Durrington, and M.I. Mackness Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 17 1997 1233 1238
16. T. Saam, J. Cai, L. Ma, Y.Q. Cai, M.S. Ferguson, N.L. Polissar, T.S. Hatsukami, and C. Yuan Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging Radiology 240 2006 464 472
17. J. Golledge, R.M. Greenhalgh, and A.H. Davies The symptomatic carotid plaque Stroke 31 2000 774 781
18. F. Guardiola, R. Codony, P.B. Addis, M. Rafecas, and J. Boatella Biological effects of oxysterols: current status Food Chem. Toxicol. 34 1996 193 211
19. A.J. Brown, and W. Jessup Oxysterols and atherosclerosis Atherosclerosis 142 1999 1 28
20. Z.H. Feng, and S. Cheng Relationship between oxysterols and atherosclerosis Sheng Li Ke Xue Jin Zhan 30 1999 23 28
21. J.N. Redgrave, J.K. Lovett, P.J. Gallagher, and P.M. Rothwell Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study Circulation 113 2006 2320 2328
22. M.J. Davies, P.D. Richardson, N. Woolf, D.R. Katz, and J. Mann Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content Br. Heart J. 69 1993 377 381
23. A.C. van der Wal, A.E. Becker, C.M. van der Loos, and P.K. Das Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44
24. J.J. Boyle Association of coronary plaque rupture and atherosclerotic inflammation J. Pathol. 181 1997 93 99
25. J.M. Grimm, A. Schindler, T. Freilinger, C.C. Cyran, F. Bamberg, C. Yuan, M.F. Reiser, M. Dichgans, C. Freilinger, K. Nikolaou, and T. Saam Comparison of symptomatic and asymptomatic atherosclerotic carotid plaques using parallel imaging and 3 T black-blood in vivo CMR J. Cardiovasc. Magn. Reson. 15 2013 44
26. M.M. Mughal, M.K. Khan, J.K. DeMarco, A. Majid, F. Shamoun, and G.S. Abela Symptomatic and asymptomatic carotid artery plaque Expert Rev. Cardiovasc. Ther. 9 2011 1315 1330
27. J. Vaya The association between biomarkers in the blood and carotid plaque composition-focusing on oxidized lipids, oxysterols and plaque status Biochem. Pharmacol. 86 2013 15 18
28. L. Hermus, J.D. Lefrandt, R.A. Tio, J.C. Breek, and C.J. Zeebregts Carotid plaque formation and serum biomarkers Atherosclerosis 213 2010 21 29
29. C. Meisinger, J. Baumert, N. Khuseyinova, H. Loewel, and W. Koenig Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population Circulation 112 2005 651 657
30. H. Tavori, M. Aviram, S. Khatib, R. Musa, D. Mannheim, R. Karmeli, and J. Vaya Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284 Free Radic. Biol. Med. 50 2011 148 156
31. E. Cohen, M. Aviram, S. Khatib, A. Rabin, D. Mannheim, R. Karmeli, and J. Vaya Increased levels of human carotid lesion linoleic acid hydroperoxide in symptomatic and asymptomatic patients is inversely correlated with serum HDL and paraoxonase 1 activity J. Lipids 2012 2012 762560
32. K. Sato, K. Nakano, S. Katsuki, T. Matoba, K. Osada, T. Sawamura, K. Sunagawa, and K. Egashira Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/ activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe J. Atheroscler. Thromb. 19 2012 986 998
33. I. Bjorkhem, O. Andersson, U. Diczfalusy, B. Sevastik, R.J. Xiu, C. Duan, and E. Lund Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages Proc. Natl. Acad. Sci. USA 91 1994 8592 8596
34. E. Lund, O. Andersson, J. Zhang, A. Babiker, G. Ahlborg, U. Diczfalusy, K. Einarsson, J. Sjovall, and I. Bjorkhem Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans Arterioscler. Thromb. Vasc. Biol. 16 1996 208 212
35. K.L. Carpenter, S.E. Taylor, J.A. Ballantine, B. Fussell, B. Halliwell, and M.J. Mitchinson Lipids and oxidised lipids in human atheroma and normal aorta Biochim. Biophys. Acta 1167 1993 121 130
36. S.M. Kim, H. Jang, Y. Son, S.A. Lee, S.S. Bae, Y.C. Park, S.K. Eo, and K. Kim 27-Hydroxycholesterol induces production of tumor necrosis factor-alpha from macrophages Biochem. Biophys. Res. Commun. 430 2013 454 459
37. M. Crisby, J. Nilsson, V. Kostulas, I. Bjorkhem, and U. Diczfalusy Localization of sterol 27-hydroxylase immuno-reactivity in human atherosclerotic plaques Biochim. Biophys. Acta 1344 1997 278 285
38. S. Luthra, J. Dong, A.L. Gramajo, M. Chwa, D.W. Kim, A. Neekhra, B.D. Kuppermann, and M.C. Kenney 7-Ketocholesterol activates caspases-3/7, -8, and -12 in human microvascular endothelial cells in vitro Microvasc. Res. 75 2008 343 350
39. G. Lizard, S. Monier, C. Cordelet, L. Gesquiere, V. Deckert, S. Gueldry, L. Lagrost, and P. Gambert Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall Arterioscler. Thromb. Vasc. Biol. 19 1999 1190 1200
40. E. Pedruzzi, C. Guichard, V. Ollivier, F. Driss, M. Fay, C. Prunet, J.C. Marie, C. Pouzet, M. Samadi, C. Elbim, Y. O'Dowd, M. Bens, A. Vandewalle, M.A. Gougerot-Pocidalo, G. Lizard, and E. Ogier-Denis NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells Mol. Cell. Biol. 24 2004 10703 10717
41. E. Nishio, and Y. Watanabe Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation Biochem. Biophys. Res. Commun. 226 1996 928 934
42. Y.C. O'Callaghan, J.A. Woods, and N.M. O'Brien Oxysterol-induced cell death in U937 and HepG2 cells at reduced and normal serum concentrations Eur. J. Nutr. 38 1999 255 262
43. S. Lemaire-Ewing, C. Prunet, T. Montange, A. Vejux, A. Berthier, G. Bessede, L. Corcos, P. Gambert, D. Neel, and G. Lizard Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols Cell Biol. Toxicol. 21 2005 97 114
44. N. Shibata, and C.K. Glass Macrophages, oxysterols and atherosclerosis Circ. J. 74 2010 2045 2051
45. L. Tesoriere, A. Attanzio, M. Allegra, C. Gentile, and M.A. Livrea Phytochemical indicaxanthin suppresses 7-ketocholesterol-induced THP-1 cell apoptosis by preventing cytosolic Ca(2+) increase and oxidative stress Br. J. Nutr. 110 2013 230 240
46. W. Li, M. Ghosh, S. Eftekhari, and X.M. Yuan Lipid accumulation and lysosomal pathways contribute to dysfunction and apoptosis of human endothelial cells caused by 7-oxysterols Biochem. Biophys. Res. Commun. 409 2011 711 716
47. A. Appukuttan, S.A. Kasseckert, S. Kumar, H.P. Reusch, and Y. Ladilov Oxysterol-induced apoptosis of smooth muscle cells is under the control of a soluble adenylyl cyclase Cardiovasc. Res. 99 2013 734 742
48. B. Buttari, L. Segoni, E. Profumo, D. D'Arcangelo, S. Rossi, F. Facchiano, R. Businaro, L. Iuliano, and R. Rigano 7-Oxo-cholesterol potentiates pro-inflammatory signaling in human M1 and M2 macrophages Biochem. Pharmacol. 86 2013 130 137
49. Y. Son, S.M. Kim, S.A. Lee, S.K. Eo, and K. Kim Oxysterols induce transition of monocytic cells to phenotypically mature dendritic cell-like cells Biochem. Biophys. Res. Commun. 438 2013 161 168
50. S. Miah, S.N. Zadeh, X.M. Yuan, and W. Li Expression of Egr1 and p53 in human carotid plaques and apoptosis induced by 7-oxysterol or p53 Exp. Toxicol. Pathol. 65 2013 677 682
51. X.M. Yuan, E. Osman, S. Miah, S.N. Zadeh, L. Xu, C. Forssell, and W. Li P53 expression in human carotid atheroma is significantly related to plaque instability and clinical manifestations Atherosclerosis 210 2010 392 399
52. S. Gargiulo, B. Sottero, P. Gamba, E. Chiarpotto, G. Poli, and G. Leonarduzzi Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: implications regarding the vulnerability of atherosclerotic lesions Free Radic. Biol. Med. 51 2011 844 855
53. S. Gargiulo, P. Gamba, G. Testa, B. Sottero, M. Maina, T. Guina, F. Biasi, G. Poli, and G. Leonarduzzi Molecular signaling involved in oxysterol-induced beta1-integrin over-expression in human macrophages Int. J. Mol. Sci. 13 2012 14278 14293
54. J.T. Salonen, K. Nyyssonen, R. Salonen, E. Porkkala-Sarataho, T.P. Tuomainen, U. Diczfalusy, and I. Bjorkhem Lipoprotein oxidation and progression of carotid atherosclerosis Circulation 95 1997 840 845
55. B. Zieden, A. Kaminskas, M. Kristenson, Z. Kucinskiene, B. Vessby, A.G. Olsson, and U. Diczfalusy Increased plasma 7 beta-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease Arterioscler. Thromb. Vasc. Biol. 19 1999 967 971
56. A. Rimner, S. Al Makdessi, H. Sweidan, J. Wischhusen, B. Rabenstein, K. Shatat, P. Mayer, and I. Spyridopoulos Relevance and mechanism of oxysterol stereospecifity in coronary artery disease Free Radic. Biol. Med. 38 2005 535 544
57. Y. Yasunobu, K. Hayashi, T. Shingu, T. Yamagata, G. Kajiyama, and M. Kambe Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols Atherosclerosis 155 2001 445 453